Contact
Please use this form to send email to PR contact of this press release:
OncBioMune Completes Enrollment in Phase 1 Trial of ProscaVax for Prostate Cancer
TO:
Please use this form to send email to PR contact of this press release:
OncBioMune Completes Enrollment in Phase 1 Trial of ProscaVax for Prostate Cancer
TO: